Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The delayed newsletter

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Aug 26, 2021 10:27am

295 Views

Post# 33766897

RE:RE:RE:RE:RE:The delayed newsletter

Rumpl3, There is a reason for this new relationship with Li Ka Shing. TLT already had a very functional lab. A relationship like this doesn't happen for no reason. I'd be surprised if we get our CR ratio up to 60ish which should be possible, if Si Ka Shing's Unity Health doesn't take us out. Not to memtion a grant if TLT starts to run out of money. They have already given away $3 BILLION (yep, with a B) in subsidies and grants. What's 10 or 20 $million amonst friends.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale